M. Saruc Et Al. , "Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.," Journal of pharmaceutical sciences , vol.92, pp.1386-95, 2003
Saruc, M. Et Al. 2003. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.. Journal of pharmaceutical sciences , vol.92 , 1386-95.
Saruc, M., Ozden, N., Turkel, N., Ayhan, S., Hock, L., Tuzcuoglu, I., ... Yuceyar, H.(2003). Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.. Journal of pharmaceutical sciences , vol.92, 1386-95.
Saruc, Murat Et Al. "Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.," Journal of pharmaceutical sciences , vol.92, 1386-95, 2003
Saruc, Murat Et Al. "Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.." Journal of pharmaceutical sciences , vol.92, pp.1386-95, 2003
Saruc, M. Et Al. (2003) . "Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.." Journal of pharmaceutical sciences , vol.92, pp.1386-95.
@article{article, author={Murat SARUC Et Al. }, title={Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.}, journal={Journal of pharmaceutical sciences}, year=2003, pages={1386-95} }